Fundraising Fox
Veratx
NASDAQ: VERASouth San Francisco, US · Founded 2016 · 359 employees on LinkedIn · 5 known investors
Find your way into Veratx
Sign up to see every warm intro you have to Veratx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veratx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
Founders & leadership
Veratx was founded in 2016 by Marshall Fordyce.
Board
Investors · 5
How we know: board seat on SEC Form D · Not right? Tell us
How we know: the S-1 prospectus · the VCSheet dataset · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$70.7M disclosed across 1 round · 2020
▶$70.7MraisedFeb 2021 · 23 investors · BiotechnologyRule 506(b)
- Marshall FordyceExecutive Officer, Director
- Andrew ChengDirector
- Scott MorrisonDirector
- Beth SeidenbergDirector
- Maha KatabiDirector
- Kurt von EmsterDirector
- Patrick EnrightDirector
- Offering amount
- $70.7M
- Amount sold
- $70.7M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
In the news
Frequently asked questions
- What does Veratx do?
- Vera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
- Who founded Veratx?
- Veratx was founded by Marshall Fordyce in 2016.
- Who are Veratx's investors?
- Veratx's investors include Kleiner Perkins, Longitude Capital, Sofinnova Ventures, Abingworth, Sofinnova Venture Partners.
- How much funding has Veratx raised?
- Veratx has disclosed $70.7M raised across 1 round.
- Where is Veratx headquartered?
- Veratx is headquartered in South San Francisco, US.